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Abstract

Background.  Late diagnoses and poor prognoses of breast cancer are common throughout Africa.  
Methods:  To identify responsible factors, we utilized data from a population-based case-control study involving 1,184 women with breast malignancies conducted in three hospitals in Accra and Kumasi, Ghana.  Interviews focused on potential breast cancer risk factors as well as factors that might contribute to presentation delays.  We calculated odds ratios (OR) and 95% confidence intervals (CI) comparing malignances with biopsy masses larger than 5 cm. (62.4% of the 1,027 cases with measurable lesions) to smaller lesions.  
Results:  In multivariate analyses, strong predictors of larger masses were limited education (OR=1.96, 95% CI 1.32-2.90 <primary vs. >senior secondary school), being separated/divorced or widowed (1.75, 1.18-2.60 and 2.25, 1.43-3.55, respectively, vs. currently married), delay in care seeking after onset of symptoms (2.64, 1.77-3.95 for >12 vs. <2 months), care having initially been sought from someone other than a doctor/nurse (1.86, 0.85-4.09), and frequent use of herbal medications/treatment (1.51, 0.95-2.43 for >3x/day usage vs. none),.  Particularly high risks associated with these factors were found among less educated women; for example, women with less than junior secondary schooling who delayed seeking care for breast symptoms for 6 months or longer were at nearly 4-times the risk of more educated women who promptly sought assistance.  
Conclusions:  Our findings suggest that additional communication, particularly among less educated women, could promote earlier breast cancer diagnoses.  Involvement of individuals other than medical practitioners, including traditional healers, may be helpful in this process.
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Introduction
	Breast cancer is becoming an increasing public health issue in Africa, with many more diagnoses anticipated in the coming years, particularly among younger women  ADDIN EN.CITE Torre, Bray (1).  As compared with western countries, it is much more common for tumors to be diagnosed at advanced stages  ADDIN EN.CITE (2).  To some extent this reflects the absence of screening in most African countries  ADDIN EN.CITE (3, 4), but other contributory factors are less well defined.  Given the importance of early diagnosis and associated treatments to cancer prognosis, it is important to define in more detail factors that might delay disease presentation.
	Studies have suggested that a variety of factors might underlie the propensity of women to delay seeking care, including being poorly educated  ADDIN EN.CITE (5, 6), specifically about the causes and treatments of breast cancer.  Several studies have demonstrated that distance that women live from health care facilities may have an impact on their presenting for timely treatment  ADDIN EN.CITE (5, 7).  Social support factors may affect prompt medical attention for breast masses, with at least one study showing later presentation of disease among single women  ADDIN EN.CITE (8).  Fear of surgery and financial impediments to receiving care are additional barriers that affect timely treatment of breast lesions  ADDIN EN.CITE (6).  In addition, in a number of African countries, it is common for women to avail themselves of traditional treatment prior to seeking western medicine, which can result in diagnosis delays  ADDIN EN.CITE (5, 9).  
	A number of studies have assessed factors affecting presentation of breast cancers in Africa, but most have involved small series of patients, collection of non-structured information, and limited data on possible contributory factors.  We therefore took advantage of data collected within the context of a large case-control study in Ghana to further address a variety of possible contributors.  Analyses were facilitated by a large number of breast cancers diagnosed in two different geographic locales (Accra and Kumasi), the collection of extensive information on various factors that could contribute to presentation delays, information on when symptoms of breast cancer were first noticed in relation to medical care attention, and patterns of seeking care from both traditional practitioners as well as western medical providers.  Analyses considered how these various factors contributed individually as well as after mutual adjustment of all identified predictors.

Methods
	The present investigation was enabled by a multi-disciplinary population-based case-control study of breast cancer in two areas of Ghana:  Accra and Kumasi, the methodology of which is described in more detail elsewhere (10).   In brief, patients for the study were recruited at the time they presented with lesions suspicious of breast cancer at three hospitals:  Korle Bu Teaching Hospital in Accra and the two hospitals Komfo Anoyke Teaching Hospital and Peace and Love Hospital in Kumasi.  These three hospitals are the primary hospitals providing surgical and treatment options for breast cancer in Ghana and thus the eligible cases represent the vast majority of diagnosed cases in the country.  Cases for this study comprised women aged 18-74 years who were from defined catchment areas (chosen to be within restricted travel times from the study hospitals given that the study also involved the recruitment of population controls from their homes) who were subsequently diagnosed with pathologically confirmed breast cancers.	
All study subjects (including population controls enrolled in the study) were interviewed in person via a detailed questionnaire that focused on established breast cancer risk factors (demographic factors, menstrual and reproductive characteristics, family history of breast cancer, medical history, occupational history, anthropometric and physical activity variables) as well as on other factors that could result in presentation delays.  This included from whom they usually sought health care, how often they visited these facilities, types of traditional medications used, travel time from their home to where they seek health care, difficulties of hardships they face when seeking health care.  For the women recruited as possible breast cancer cases, additional questions were asked regarding when they first noticed a breast problem, the type of problems, when they first sought help and who they first saw for help or treatment.  
Interviews were conducted in-hospital by standardly trained personnel, who recorded answers to questions on detailed questionnaires.  Following the interview, interviewers were requested to record the length of the interview and rate the patient’s extent of cooperation (very good, good, fair, poor) as well as the overall quality of the interview (high quality, generally reliable, questionable, unsatisfactory).
	Core biopsy material obtained from women prior to treatment was prepared as H&E slides to enable pathologists in Ghana to assign histopathologic diagnoses.  At the time of biopsy, data were recorded by nurses and physicians on the presenting symptoms, number of lumps/masses present, and the approximate size of the lumps/masses from which biopsies were obtained.  Data from medical records were also abstracted onto case abstract forms to capture information on additional clinical parameters of interest, including size of the mass at presentation, cancer stage and grade, and extent of metastases (if relevant).
	Odds ratios (OR) and 95% confidence intervals (CI) were calculated for larger (> 5 cm) versus smaller (< 5 cm) tumors as related to a variety of potential factors that could contribute to presentation delays.  Initially, all factors were considered individually, after adjustment for study site and age (as a continuous variable).  Multivariate models enabled simultaneous adjustment for factors that had shown significant associations in minimally-adjusted models.  In order to identify subjects at highest risks of presenting with larger tumors, risks were also calculated using a common referent, notably more highly educated women who were at lowest risk in terms of other risk predictors (e.g., those who sought prompt medical attention for breast symptoms).

Results
	A majority of the 1,184 patients diagnosed with malignant breast cancers were under 50 years of age, with the median age at diagnosis being 49 years (Table 1). A total of 1,027 of the patients (86.7%) had measurable masses at the time of their biopsies, with 157 (13.3%) showing either no palpable lump (n=4) or having missing data on tumor size (n=153).  Of those cases with measurable tumor sizes, 39 (3.8%) had tumors <2 cm, 347 (33.8%) had tumors >2-5 cm. and 641 had (62.4%) tumors > 5 cm in size.  The presenting symptom in almost all cases was a lump or mass, although some patients also presented with pain or tenderness or change in breast size.  Other symptoms (e.g., skin dimpling, skin ulcerations or rashes) were less commonly represented.
	In analyses to identify risk factors related to presentation of larger (>5 cm) compared to smaller (<5 cm) tumors, we utilized data from completed questionnaires (obtained from 99.1% of eligible cases) and initially focused on a variety of socio-demographic factors, adjusted only for study site and age (Table 2).  One of the major predictors of risk was low education, with subjects having no formal education or merely some primary school having an OR of 2.11 (95% CI 1.47-3.04) compared to those with senior secondary/vocational/university education.   As compared with currently married women, elevated ORs were observed for divorced/ separated or widowed women, risks that remained significant even after adjustment for education (respective ORs and 95% CI of 1.70, 1.18-2.46 and 2.14, 1.40-3.27).  Single patients were not at increased risk.  Although prior to adjustment for education, a number of factors were associated with significantly increased risks of presentation with larger tumors—including not owning a television, car, truck, refrigerator, or computer, most of these factors no longer remained significantly associated with risk after adjustment for education.  
A variety of medical factors were also assessed in relation to tumor sizes at presentation (Table 3).  After adjustment for education, significant predictors of larger tumor masses included reporting long periods of time before care was sought after the onset of breast symptoms (OR=1.81, 1.24-2.65 for 12 months or longer vs. 2 months or less) and seeking assistance from someone other than a doctor or nurse for breast symptoms (2.65, 1.31-5.40).  Ever having seen a traditional healer and visiting a traditional healer more than once a year were only marginally associated with increased risk (risk increases of approximately 30%), but subjects who reported using traditional medications or treatments for 3 or more times per day were at a significantly increased risk (OR=1.67, 1.07-2.62).  Whether usual care was received from a doctor or nurse vs. some other provider, frequency of visits to a doctor or nurse, travel times to get to a health facility, and reported financial or other difficulties in seeking health care were not substantially related to risk, either before or after adjustment for education.   
When we simultaneously adjusted for all substantial predictors of larger masses (Table 4), the factors that remained significantly associated with presentation of large masses were limited education, being divorced/separated/widowed, and having delayed seeking treatment after the onset of breast symptoms.  The reporting of help for breast symptoms by someone other than a doctor or nurse and frequent use of traditional medications or treatments remained elevated, although became non-significant after adjustment for other identified risk factors.
We conducted additional multivariate analyses of predictors of large masses according to subgroups defined on the basis of study site (Accra vs. Kumasi) and age at diagnosis (<50 vs. >50 years).  For the most part, our identified predictors of larger masses prevailed across all subgroups, including patients diagnosed in both the predominantly urban Accra and the more rural site of Kumasi, and in younger versus older subjects.
Finally, we assessed risks of presentation with larger tumors, comparing all risks to the more highly educated patients who had lower risk profiles (e.g., currently married) (Table 6).  This demonstrated exceptionally high risks for less educated women who were divorced, separated or divorced (OR=4.03, 95% CI 2.50-6.49) or single (5.98, 1.32-27.07), were taking traditional medications three or more times per day (5.35, 2.94-12.05), and delayed seeking treatment for 6 or more months (3.80, 2.37-6.10)—risks that were much higher than women with higher levels of education with comparable risk profiles.  There was less distinction according to education by whether care was initially sought for breast cancer symptoms from someone other than a doctor or nurse, with both more and less educated women at significantly high risks (respective risks of 2.92 vs. 3.75).

Discussion
	In this study, we identified a number of parameters that were associated with presentation with larger breast masses.  Many of the variables identified in initial analyses (e.g., absence of a computer or car) appeared to primarily be reflections of limited levels of education, which was a significant predictor in multivariate analyses.  In addition to low educational levels, we also identified that not currently being married, regularly taking herbal medications, not seeking prompt attention for breast problems, and seeking medical care from someone other than a doctor or nurse were related to diagnoses of larger breast cancers.
	Similar to many other investigations  ADDIN EN.CITE (5, 6, 8, 11), we found that limited education was a major predictor of late breast cancer presentation, most likely reflecting a lack of awareness regarding signs and symptoms of cancer, as has been documented for most African countries  ADDIN EN.CITE (11, 12), including Ghana  ADDIN EN.CITE (13).  A survey from the Union for International Cancer Control (UICC) showed that approximately 25% of Africans surveyed believed that cancer had no cure, and only 36% believed cancer was a major health issue (14).  In a low-resource community in South Africa, over 80% of the women were unaware of the warning signs of breast cancer, with lack of knowledge being more common among older and rural women (15).  It is common in Africa that there are also a variety of misconceptions about the disease, with some women believing that the disease is caused by a spiritual affliction  ADDIN EN.CITE (6), and others under the impression that breast cancer is preventable by vaccination, with only limited proportions recognizing the efficacy of breast examination  ADDIN EN.CITE (16).  
Thus, education is clearly an important component of breast cancer prevention, with our study, as well as others, stressing the importance of focusing on less well educated women to provide them with knowledge regarding  the causes of breast cancer and the importance of timely treatment.  Women should be encouraged to become familiar with their breasts and seek medical attention at the first sign on unusual symptoms.  Targeted efforts among less well educated women appear especially important, as evidenced by data from a Nigerian study that found that participants with higher education were 3.6 times more likely to practice breast self-examination (BSE) than those with lower education levels (12).  Our study confirmed the importance of targeted communication efforts given that we found that poorly educated women who delayed seeking treatment were at nearly 4 times the risk of better educated women who sought timely treatment.  Further, effective communication may need to account for addressing issues in easy to understand terms and in local dialects that are easily understood (17).
	Although limited education clearly impedes women from seeking timely medical assistance for their breast problems, this was not the sole explanation for delays, as both limited education and time between problems emerging and seeking treatment remained as independent predictors of risk in our study.  In many African countries, women believe that a diagnosis of breast cancer is a death sentence, mainly because their only experience with the disease is through friends and relatives who have sought medical help when it is too late and treatment is ineffective  ADDIN EN.CITE (6).  Costs of care  ADDIN EN.CITE (18) or lack of awareness of health care coverage  ADDIN EN.CITE (19) can also be an impediment to women seeking medical care especially since costs of a biopsy, pathology, surgery, radiotherapy and chemotherapy often need to be covered by the patients.  Finally, there are reports that women avoid medical care because of a fear of mastectomy  ADDIN EN.CITE (8, 20), especially given documented instances of husbands leaving their wives after such procedures  ADDIN EN.CITE (21).
	Given some evidence that married women avoid medical care because of a fear that their husbands might leave them after a diagnosis of breast cancer, it was somewhat surprising that we found that being widowed, divorced or separated was associated with a greater risk of late presentation as compared to being currently married.  Other studies have found that single women tend to delay presentation  ADDIN EN.CITE (8), a factor in our study that only increased late presentation among poorly educated women.  In aggregate our findings suggest the importance of family support in contributing to a timely diagnosis of breast cancer, consistent with results from another investigation  ADDIN EN.CITE (22).  However, we could not determine which aspect of family support might be most important in the process.  It is likely that married women would have daughters who might be more informed about breast cancer and that daughters might be more important in the process than husbands.  Further research would be useful to determine what support systems might be most useful in promoting earlier diagnoses.
It is well documented in Africa that effective treatment can be hindered by women initially seeking care from traditional healers or alternative practitioners  ADDIN EN.CITE (5, 23-26).  Our study provided further some support for this notion by showing a non-significantly increased risk associated with women reporting use of 3 or more herbal treatments per day.  Studies have documented that use of traditional healers is linked with substantial delays in patients presenting to hospitals  ADDIN EN.CITE (24, 27).  It is not unusual for women to initially seek care through a traditional healer, with care sought from hospitals only after traditional care has been unsuccessful  ADDIN EN.CITE (11).  To overcome this problem, it has been recommended that traditional healers be integrated appropriately into hospital settings to accommodate cultural preferences and beliefs  ADDIN EN.CITE (28).
Not surprisingly, we found that delaying attention for breast symptoms was independently associated with larger tumors at diagnosis.  Given the attenuation in risks after adjustment for educational level, some of this association may have been due to lack of knowledge of the importance of early diagnoses.  However, the fact that the association with delays persisted after adjustment for other predictors of late diagnosis suggested that other factors might have contributed, including some of the social factors previously discussed.
Dissimilar to one previous investigation  ADDIN EN.CITE (7), we did not identify that longer distances from a health facility was a significant predictor of larger breast masses.  This may reflect that, for logistical reasons related to recruitment of population controls in our study, we restricted the catchment area of cases to areas around the study hospitals.  With restricted travel times, we did note a slightly higher risk of presentation with large tumors for subjects who needed to travel the longest distances to our study hospitals, but this association appeared to reflect an influence of limited education--with the relation disappearing after adjustment for this factor.
Given the documented rise in the number of breast cancers across Africa and the fact that treatment options are limited for late stage tumors, it is clear that further efforts must be made to stress the importance of early diagnosis.  The social issues underlying educating and encouraging prompt medical attention are, however, complex, and intertwined with long-held beliefs about the origins of the disease and the most effective ways of approaching treatment (17).  Changing these beliefs will be challenging, and will involve not only the patient but her immediate family—especially given fiscal constraints involved with diagnoses and treatment.  The lack of screening facilities has been viewed as a major impediment to earlier detection of breast cancers in Africa, but at least one study has concluded that dealing with the causes of delayed presentation appears more important than attempts to screen for breast cancer, since patients identified through community screening still present late (20).  Although future translational efforts will be challenging, our study has identified some of the factors that may be contributing to late presentation of disease, which may be useful in addressing impediments to early detection of diseases—which is critical to imparting effective treatments.

Word count=2,949 (limit 3,0000)


Ghana Breast Health Study Team
Korle Bu Teaching Hospital:  Dr. Anthony Adjei, Dr. Florence Dedey, Dr. Verna Vanderpuye, Victoria Okyne, Naomi Ohene Oti, Evelyn Tay, Dr. Adu-Aryee, Angela Kenu, Obed Ekpedzor
 
Komfo Anoyke Teaching Hospital:  Dr. Francis Aitpillah, Dr. Joseph Oppong, Dr. Ernest Osei-Bonsu, Dr. Nicholas Titiloye, Isaac Boakye, Bernard Arhin, Emmanuel Assimah, Samuel Ka-chungu

Peace and Love Hospital, Kumasi, Ghana:  Prof. Margaret Frempong, Emma Brew Abaidoo, Bridget Nortey Mensah, Samuel Amanama, Prince Agyuapong, Debora Boateng-Ansong, Thomas Agyei, Richard Opoku, Kofi Owusu Gyimah

National Cancer Institute, Bethesda, MD:  Dr. Stephen Hewitt, Maya Palakal, Jake Thistle

University of Michigan, Ann Arbor, MI:  Dr. Lisa Newman

Westat, Inc.:  Michelle Brotzman, Shelley Niwa, Usha Singh
	



References1.	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.2.	Brinton LA, Figueroa JD, Awuah B, Yarney J, Wiafe S, Wood SN, et al. Breast cancer in Sub-Saharan Africa: opportunities for prevention. Breast Cancer ResTreat. 2014;144(3):467-78.3.	Cui Y, Page DL, Lane DS, Rohan TE. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study. Breast Cancer Res Treat. 2009;114(1):113-20.4.	Galukande M, Kiguli-Malwadde E. Rethinking breast cancer screening strategies in resource-limited settings. AfrHealth Sci. 2010;10(1):89-92.5.	Pace LE, Mpunga T, Hategekimana V, Dusengimana JM, Habineza H, Bigirimana JB, et al. Delays in Breast Cancer Presentation and Diagnosis at Two Rural Cancer Referral Centers in Rwanda. Oncologist. 2015;20(7):780-8.6.	Pruitt L, Mumuni T, Raikhel E, Ademola A, Ogundiran T, Adenipekun A, et al. Social barriers to diagnosis and treatment of breast cancer in patients presenting at a teaching hospital in Ibadan, Nigeria. Glob Public Health. 2015;10(3):331-44.7.	Dickens C, Joffe M, Jacobson J, Venter F, Schuz J, Cubasch H, et al. Stage at breast cancer diagnosis and distance from diagnostic hospital in a periurban setting: a South African public hospital case series of over 1,000 women. Int J Cancer. 2014;135(9):2173-82.8.	Ibrahim NA, Oludara MA. Socio-demographic factors and reasons associated with delay in breast cancer presentation: a study in Nigerian women. Breast. 2012;21(3):416-8.9.	Clegg-Lamptey JN, Dakubo JC, Attobra YN. Psychosocial aspects of breast cancer treatment in Accra, Ghana. East AfrMedJ. 2009;86(7):348-53.10.	Brinton L FJ, Adjei E, Aitpillah F, Ansong D, Arhin B, Biritwum R, Boakye I, Brotzman M, Edusei L, Nyante S, Nyarko K, Oppong J, Osei-Bonsu E, Vanderpuye V, Wiafe S, Yarney J, Awuah B, Clegg-Lamptey JN, Wiafe-Addai B. Opportunities and challengs for conducting a population-based multidisciplinary study of breast cancer in Africa. 2016.11.	Opoku SY, Benwell M, Yarney J. Knowledge, attitudes, beliefs, behaviour and breast cancer screening practices in Ghana, West Africa. Pan AfrMedJ. 2012;11:28.12.	Okobia MN, Bunker CH, Okonofua FE, Osime U. Knowledge, attitude and practice of Nigerian women towards breast cancer: a cross-sectional study. World J SurgOncol. 2006;4:11.13.	Mena M, Wiafe-Addai B, Sauvaget C, Ali IA, Wiafe SA, Dabis F, et al. Evaluation of the impact of a breast cancer awareness program in rural Ghana: a cross-sectional survey. Int J Cancer. 2014;134(4):913-24.14.	Machlin A WM, Spittal M, Hill D. Cancer related beliefs and behaviours in eight geographic regions. 2009.15.	Pillay AL. Rural and urban South African women's awareness of cancers of the breast and cervix. EthnHealth. 2002;7(2):103-14.16.	Suh MA, Atashili J, Fuh EA, Eta VA. Breast self-examination and breast cancer awareness in women in developing countries: a survey of women in Buea, Cameroon. BMCResNotes. 2012;5:627.17.	Asobayire A, Barley R. Women's cultural perceptions and attitudes towards breast cancer: Northern Ghana. Health Promot Int. 2015;30(3):647-57.18.	Okoronkwo IL, Ejike-Okoye P, Chinweuba AU, Nwaneri AC. Financial barriers to utilization of screening and treatment services for breast cancer: an equity analysis in Nigeria. Niger J Clin Pract. 2015;18(2):287-91.19.	Obrist M, Osei-Bonsu E, Awuah B, Watanabe-Galloway S, Merajver SD, Schmid K, et al. Factors related to incomplete treatment of breast cancer in Kumasi, Ghana. Breast. 2014;23(6):821-8.20.	Clegg-Lamptey J, Dakubo J, Attobra YN. Why do breast cancer patients report late or abscond during treatment in ghana? A pilot study. GhanaMedJ. 2009;43(3):127-31.21.	Odigie VI, Tanaka R, Yusufu LM, Gomna A, Odigie EC, Dawotola DA, et al. Psychosocial effects of mastectomy on married African women in Northwestern Nigeria. Psychooncology. 2010;19(8):893-7.22.	Odongo J, Makumbi T, Kalungi S, Galukande M. Patient delay factors in women presenting with breast cancer in a low income country. BMC Res Notes. 2015;8:467.23.	De Ver DT, Bogale S, Hobden C, Tilahun Y, Hechter V, Deressa T, et al. A mixed-method assessment of beliefs and practice around breast cancer in Ethiopia: implications for public health programming and cancer control. GlobPublic Health. 2011;6(7):719-31.24.	Ezeome ER. Delays in presentation and treatment of breast cancer in Enugu, Nigeria. NigerJ ClinPract. 2010;13(3):311-6.25.	Ntirenganya F, Petroze RT, Kamara TB, Groen RS, Kushner AL, Kyamanywa P, et al. Prevalence of breast masses and barriers to care: results from a population-based survey in Rwanda and Sierra Leone. J Surg Oncol. 2014;110(8):903-6.26.	O'Brien KS, Soliman AS, Annan K, Lartey RN, Awuah B, Merajver SD. Traditional herbalists and cancer management in Kumasi, Ghana. J Cancer Educ. 2012;27(3):573-9.27.	Clegg-Lamptey J, Hodasi W. A study of breast cancer in korle bu teaching hospital: assessing the impact of health education. GhanaMedJ. 2007;41(2):72-7.28.	Yarney J, Donkor A, Opoku SY, Yarney L, Agyeman-Duah I, Abakah AC, et al. Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study. BMCComplement AlternMed. 2013;13:16.

1.	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.
2.	Brinton LA, Figueroa JD, Awuah B, Yarney J, Wiafe S, Wood SN, et al. Breast cancer in Sub-Saharan Africa: opportunities for prevention. Breast Cancer ResTreat. 2014;144(3):467-78.
3.	Cui Y, Page DL, Lane DS, Rohan TE. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study. Breast Cancer Res Treat. 2009;114(1):113-20.
4.	Galukande M, Kiguli-Malwadde E. Rethinking breast cancer screening strategies in resource-limited settings. AfrHealth Sci. 2010;10(1):89-92.
5.	Pace LE, Mpunga T, Hategekimana V, Dusengimana JM, Habineza H, Bigirimana JB, et al. Delays in Breast Cancer Presentation and Diagnosis at Two Rural Cancer Referral Centers in Rwanda. Oncologist. 2015;20(7):780-8.
6.	Pruitt L, Mumuni T, Raikhel E, Ademola A, Ogundiran T, Adenipekun A, et al. Social barriers to diagnosis and treatment of breast cancer in patients presenting at a teaching hospital in Ibadan, Nigeria. Glob Public Health. 2015;10(3):331-44.
7.	Dickens C, Joffe M, Jacobson J, Venter F, Schuz J, Cubasch H, et al. Stage at breast cancer diagnosis and distance from diagnostic hospital in a periurban setting: a South African public hospital case series of over 1,000 women. Int J Cancer. 2014;135(9):2173-82.
8.	Ibrahim NA, Oludara MA. Socio-demographic factors and reasons associated with delay in breast cancer presentation: a study in Nigerian women. Breast. 2012;21(3):416-8.
9.	Clegg-Lamptey JN, Dakubo JC, Attobra YN. Psychosocial aspects of breast cancer treatment in Accra, Ghana. East AfrMedJ. 2009;86(7):348-53.
10.	Brinton L FJ, Adjei E, Aitpillah F, Ansong D, Arhin B, Biritwum R, Boakye I, Brotzman M, Edusei L, Nyante S, Nyarko K, Oppong J, Osei-Bonsu E, Vanderpuye V, Wiafe S, Yarney J, Awuah B, Clegg-Lamptey JN, Wiafe-Addai B. Opportunities and challengs for conducting a population-based multidisciplinary study of breast cancer in Africa. 2016.
11.	Opoku SY, Benwell M, Yarney J. Knowledge, attitudes, beliefs, behaviour and breast cancer screening practices in Ghana, West Africa. Pan AfrMedJ. 2012;11:28.
12.	Okobia MN, Bunker CH, Okonofua FE, Osime U. Knowledge, attitude and practice of Nigerian women towards breast cancer: a cross-sectional study. World J SurgOncol. 2006;4:11.
13.	Mena M, Wiafe-Addai B, Sauvaget C, Ali IA, Wiafe SA, Dabis F, et al. Evaluation of the impact of a breast cancer awareness program in rural Ghana: a cross-sectional survey. Int J Cancer. 2014;134(4):913-24.
14.	Machlin A WM, Spittal M, Hill D. Cancer related beliefs and behaviours in eight geographic regions. 2009.
15.	Pillay AL. Rural and urban South African women's awareness of cancers of the breast and cervix. EthnHealth. 2002;7(2):103-14.
16.	Suh MA, Atashili J, Fuh EA, Eta VA. Breast self-examination and breast cancer awareness in women in developing countries: a survey of women in Buea, Cameroon. BMCResNotes. 2012;5:627.
17.	Asobayire A, Barley R. Women's cultural perceptions and attitudes towards breast cancer: Northern Ghana. Health Promot Int. 2015;30(3):647-57.
18.	Okoronkwo IL, Ejike-Okoye P, Chinweuba AU, Nwaneri AC. Financial barriers to utilization of screening and treatment services for breast cancer: an equity analysis in Nigeria. Niger J Clin Pract. 2015;18(2):287-91.
19.	Obrist M, Osei-Bonsu E, Awuah B, Watanabe-Galloway S, Merajver SD, Schmid K, et al. Factors related to incomplete treatment of breast cancer in Kumasi, Ghana. Breast. 2014;23(6):821-8.
20.	Clegg-Lamptey J, Dakubo J, Attobra YN. Why do breast cancer patients report late or abscond during treatment in ghana? A pilot study. GhanaMedJ. 2009;43(3):127-31.
21.	Odigie VI, Tanaka R, Yusufu LM, Gomna A, Odigie EC, Dawotola DA, et al. Psychosocial effects of mastectomy on married African women in Northwestern Nigeria. Psychooncology. 2010;19(8):893-7.
22.	Odongo J, Makumbi T, Kalungi S, Galukande M. Patient delay factors in women presenting with breast cancer in a low income country. BMC Res Notes. 2015;8:467.
23.	De Ver DT, Bogale S, Hobden C, Tilahun Y, Hechter V, Deressa T, et al. A mixed-method assessment of beliefs and practice around breast cancer in Ethiopia: implications for public health programming and cancer control. GlobPublic Health. 2011;6(7):719-31.
24.	Ezeome ER. Delays in presentation and treatment of breast cancer in Enugu, Nigeria. NigerJ ClinPract. 2010;13(3):311-6.
25.	Ntirenganya F, Petroze RT, Kamara TB, Groen RS, Kushner AL, Kyamanywa P, et al. Prevalence of breast masses and barriers to care: results from a population-based survey in Rwanda and Sierra Leone. J Surg Oncol. 2014;110(8):903-6.
26.	O'Brien KS, Soliman AS, Annan K, Lartey RN, Awuah B, Merajver SD. Traditional herbalists and cancer management in Kumasi, Ghana. J Cancer Educ. 2012;27(3):573-9.
27.	Clegg-Lamptey J, Hodasi W. A study of breast cancer in korle bu teaching hospital: assessing the impact of health education. GhanaMedJ. 2007;41(2):72-7.
28.	Yarney J, Donkor A, Opoku SY, Yarney L, Agyeman-Duah I, Abakah AC, et al. Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study. BMCComplement AlternMed. 2013;13:16.




2



